Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1997 Oct;50(5):257–260. doi: 10.1136/mp.50.5.257

Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.

R Chetty 1, S Chetty 1
PMCID: PMC379642  PMID: 9497916

Abstract

AIMS: To assess the immunoexpression of cyclin D1 and retinoblastoma in a cohort of oesophageal squamous cell carcinoma cases from South Africa to see whether there is a relation between these two proteins. In addition, protein expression was correlated with clinicopathological features. METHODS: Fifty biopsies and 30 oesophagectomy specimens were immunostained with commercially available antibodies to cyclin D1 and retinoblastoma proteins, following microwave antigen retrieval. RESULTS: Twenty three of the 80 cases (29%) showed cyclin D1 protein expression. However, only five cases had > 50% of the tumour cells displaying immunopositivity. Three of the four cases with lymph node spread were cyclin D1 positive in the primary tumour and the metastasis. Fifty three cases were immunoreactive with the antiretinoblastoma antibody; 29 of these cases showing > 50% of cells with immunolabelling. Of the 23 cyclin D1 positive cases, 18 were also retinoblastoma positive. No correlation was observed between cyclin D1 and retinoblastoma protein expression and age, sex, race, or histological grade. CONCLUSIONS: Cyclin D1 is expressed in a minority of cases of oesophageal squamous carcinomas from South Africa. However, three of four cases with lymph node spread were cyclin D1 positive, thus indicating that cyclin D1 positive tumours may have a greater propensity for spread. In addition, 18 of 23 cyclin D1 positive cases also expressed retinoblastoma protein. These findings suggest a possible relation between cyclin D1 and retinoblastoma proteins in a proportion of cases of oesophageal squamous.

Full text

PDF
257

Images in this article

258Image
on p.258
259Image
on p.259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cance W. G., Brennan M. F., Dudas M. E., Huang C. M., Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med. 1990 Nov 22;323(21):1457–1462. doi: 10.1056/NEJM199011223232105. [DOI] [PubMed] [Google Scholar]
  2. Constância M., Seruca R., Carneiro F., Silva F., Castedo S. Retinoblastoma gene structure and product expression in human gastric carcinomas. Br J Cancer. 1994 Nov;70(5):1018–1024. doi: 10.1038/bjc.1994.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cordon-Cardo C., Richon V. M. Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol. 1994 Mar;144(3):500–510. [PMC free article] [PubMed] [Google Scholar]
  4. Cordon-Cardo C., Wartinger D., Petrylak D., Dalbagni G., Fair W. R., Fuks Z., Reuter V. E. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst. 1992 Aug 19;84(16):1251–1256. doi: 10.1093/jnci/84.16.1251. [DOI] [PubMed] [Google Scholar]
  5. Gologorskii V. A., Gel'fand B. R., Stamov V. I., Lapshina I. Iu. Prekrashchenie dlitel 'noi iskusstvennoi ventiliatsii legkikh ("otluchenie ot apparata IVL"). Funktsional 'nye kriterii i metodicheskie. Anesteziol Reanimatol. 1995 Nov-Dec;(6):64–71. [PubMed] [Google Scholar]
  6. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science. 1994 Dec 16;266(5192):1821–1828. doi: 10.1126/science.7997877. [DOI] [PubMed] [Google Scholar]
  7. Holm R., Nesland J. M. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol. 1994 Mar;172(3):267–272. doi: 10.1002/path.1711720307. [DOI] [PubMed] [Google Scholar]
  8. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994 Nov 18;79(4):573–582. doi: 10.1016/0092-8674(94)90543-6. [DOI] [PubMed] [Google Scholar]
  9. Jiang W., Zhang Y. J., Kahn S. M., Hollstein M. C., Santella R. M., Lu S. H., Harris C. C., Montesano R., Weinstein I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9026–9030. doi: 10.1073/pnas.90.19.9026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lee W. H., Shew J. Y., Hong F. D., Sery T. W., Donoso L. A., Young L. J., Bookstein R., Lee E. Y. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987 Oct 15;329(6140):642–645. doi: 10.1038/329642a0. [DOI] [PubMed] [Google Scholar]
  11. Martínez J. C., Piris M. A., Sánchez-Beato M., Villuendas R., Orradre J. L., Algara P., Sánchez-Verde L., Martínez P. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol. 1993 Apr;169(4):405–412. doi: 10.1002/path.1711690404. [DOI] [PubMed] [Google Scholar]
  12. Naitoh H., Shibata J., Kawaguchi A., Kodama M., Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol. 1995 May;146(5):1161–1169. [PMC free article] [PubMed] [Google Scholar]
  13. Sheyn I., Noffsinger A. E., Heffelfinger S., Davis B., Miller M. A., Fenoglio-Preiser C. M. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol. 1997 Mar;28(3):270–276. doi: 10.1016/s0046-8177(97)90123-4. [DOI] [PubMed] [Google Scholar]
  14. Shinozaki H., Ozawa S., Ando N., Tsuruta H., Terada M., Ueda M., Kitajima M. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res. 1996 Jul;2(7):1155–1161. [PubMed] [Google Scholar]
  15. Stemmermann G., Heffelfinger S. C., Noffsinger A., Hui Y. Z., Miller M. A., Fenoglio-Preiser C. M. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol. 1994 Oct;25(10):968–981. doi: 10.1016/0046-8177(94)90056-6. [DOI] [PubMed] [Google Scholar]
  16. Xu H. J., Hu S. X., Benedict W. F. Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene. 1991 Jul;6(7):1139–1146. [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES